SB 522 Maryland Senate · 2018 Regular Session

Health Care Providers - Opioid and Benzodiazepine Prescriptions - Discussion of Benefits and Risks

Bill status signed all 5 stages cleared
Introduction
Jan 2018
Committee Review
Apr 2018
Senate Passage
Apr 2018
House of Delegates Passage
Apr 2018
Signed into Law
Apr 2018
Introduced Jan 29, 2018 Signed Apr 24, 2018
Floor votes · Senate Mar 19, 2018 · House of Delegates Apr 6, 2018

How they voted

370
Passed
Total votes 37
Mar 19, 2018
D Democratic27
27 Yea
100% Yea
R Republican10
10 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
16
Key actions
9
Committee
6
Amendments
1
Apr 24, 2018
Signed into law
Approved by the Governor - Chapter 216
executive
Apr 9, 2018
Upper · Passed
Passed Enrolled
upper
Apr 9, 2018
Upper · Passed
Third Reading Passed (45-0)
upper
Apr 9, 2018
Introduced
Senate Concur - House Amendments
upper
Apr 6, 2018
Lower · Passed
Third Reading Passed with Amendments (130-4)
lower
Apr 6, 2018
Lower · Passed
Favorable with Amendments {426989/1 Report Adopted
lower
Apr 6, 2018
Lower · Passed
Favorable with Amendments Report by Health and Government Operations
lower
Mar 20, 2018
Committee
First Reading Health and Government Operations
lower
Mar 19, 2018
Upper · Passed
Third Reading Passed (47-0)
upper
Mar 16, 2018
Upper · Passed
Favorable with Amendments {434233/1 Report Adopted
upper
Mar 16, 2018
Upper · Passed
Favorable with Amendments Report by Education, Health, and Environmental Affairs
upper
Jan 29, 2018
Committee
First Reading Education, Health, and Environmental Affairs
upper
1 primary · 7 co-sponsors

Sponsors